Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium avium complex disease, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease	Active, not recruiting	Phase 2	2026-05-06		NCT02968212

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Heart, Lung, and Blood Institute (NHLBI)	791
National Institute of Allergy and Infectious Diseases (NIAID)	402
National Jewish Health	31
Oregon Health and Science University	244
Temple University	60
The University of Texas Health Science Center at Tyler	3
University of Chicago	326
University of South Florida	110

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Louisiana State University	Baton Rouge	United States	3
National Jewish Health	Denver	United States	72
Oregon Health & Science University	Portland	United States	261
University of Chicago	Chicago	United States	312
University of South Florida	Tampa	United States	33
University of Texas Health Science Center	Tyler	United States	2